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2. 1.2 (Permutation test)
(Sobs)
$S=\sum_{i=1}^{n}(Y_{i}-\overline{Y}_{n})T_{Z}$
$i$ $(i=1,2, \cdots, N)$ $g$























$P$- -$P=(\sum Y_{1}+\sum Y_{0})/(N_{1}+N_{0})$
2.1.5 Fisher’s exact test
Fisher’s exact test
Fisher’s exact test



















































4 $X_{1},X_{2},X_{3},X_{4}$ $X_{1}$ $0$ 1
$X_{1}$ 1 $0$ 0.5 $X_{2}$ $0$ 3 $X_{2}$
95
3 0.33 $0$ 0.67 $X_{3}$ $0_{\backslash }1$ $2$ 5
$X_{3}$ $0$ $0.5$ $1$ $0.3$ $2$ $0.1$ $5$ 0.1
























Situation 1 Situation 2 (Dx)
Z3 2 5 1 $0$
1 Situationl Situation2
Koch
$(\alpha$ $)$ 0.05 5000
3
3. $1CA$
$Y_{1}$ Group 1 $Y_{2}$ Group 2 $0$ 1 2
Group 1 $N_{1 }$ Group 2 $N_{2}$ $N$ $N=N_{1}+N_{2}$
$Y_{1}$ $P_{1 }Y_{2}$ $P_{2}$ $Y_{1}$ $Y_{2}$
$Y_{1}\sim bin(N_{1}, P_{1})$ $Y_{2}\sim bin(N_{2}, P_{2})$ $Z_{1}$
$Y_{lZ1 }$ Y2 Zl $P_{lZ1 }P_{2}$ Zl $N_{lZ1 }N_{2Z1}$ $Z_{2}$ $Y_{lZ2 }Y_{2}$ Z2
$P_{lZ2 }P_{2Z2 }$ $N_{lZ2 }N_{2Z2}$ $Z_{1}$ $Z_{2}$
$0$ $Y_{lZ1}\sim bin(N_{lZ1}, P_{lZ1})$ $var(Y_{lZ1})$
var$( Y_{lZ1})=\frac{P_{lZ1}(1-P_{lZ1})}{N_{1Z1}}$




























$\grave{}$ Type Ierror $0.0164$ Fisher’s exact test 0.0108
$0.0484$ Boots ap $0.0540$ Koch $0.0526$ Zhang 0.0478






The value of $q$ at formula (1)




Type Ierror $0.0188$ Fisher’s exact test $0.00134$
$0.0488$ Bootsffap $0.0474$ Koch $0.0536$ Zhang 0.0481




The value of $q$ at formula $(1\rangle$
Fig.4 Simulation results power for 3.2.1.2 $(a=0.055000runsN=192K=4)$
3.2.1.3. $P=2/3$
$P=2/3$
Type Ierror $0.0226$ Fisher’s exact test 0.0156
$0.0528$ Bootsbap $0.0466$ Koch $0.0496$ Zhang 0.0538





The value of $q$ at formula (1)





Type Ierror $0.0204$ Fisher’s exact test 0.0114
0.0506. Bootstrap $0.0488$ Koch $0.0486$ Zhang 0.0382









$OD$ 0.1 0.2 03 $0A$ $O$ .5 06 0.7 $oS$ 0.$9$ $1D$
The value of $q$ at formula (1)
Fig.6 Simulation results power for 3.2.2.1 $(a=0.055000runsN=192K=4)$
3.2.2.2. $P=4/5$
$P=4/5$
Type Ierror $0.0204$ Fisher’s exact test 0.0140
$0.0476$ Bootsbap $0.0510$ Koch $0.0526$ Zhang 0.0479
Koch Bootstrap Zhang Fisher’s
exact test
$\overline{arrow ov\geq}$
$OD$ 0. $1$ 0. $2$ 03 04 $0S$ 0. $6$ 0. $7$ 0.8 $OS$ $1D$
The value of $q$ at formula (1)




Type Ierror $0.0238$ Fisher’s exact test 0.0190
$0.0484$ Boots ap $0.0452$ Koch $0.0540$ Zhang 0.0566





The value of $q$ at formula $(1\rangle$




Type Ierror $0.0148$ Fisher’s exact test 0.0096
$0.0448$ $Boots\alpha ap$ $0.0462$ Koch $0.0478$ Zhang 0.0560






The value of $q$ at formula (1)




Type Ierror $0.0158$ Fisher’s exact test 0.0120
$0.0532$ Bootstrap $0.0518$ Koch $0.0520$ Zhang 0.0567





The value of $q$ at formula $(1\rangle$
Fig.10 Simulation results power for 3.2.3.2 $(a=0.055000runsN=192K=4)$
3.2.3.3. $P=2/3$
$P=2/3$
Type Ierror $0.0166$ Fisher’s exact test 0.0128
$0.0464$ Bootstrap 0.03 $88$ Koch $0.0450$ Zhang 0.0494
Zhang Koch $B$ ootstrap Fisher’s
exact test
$o_{-}^{O}\Phi\geqarrow$
The value of $q$ at formula (1)





















Bootstrap $P=4/5$ Situation 1
$P=1$ 6% $CA$
$P=2/3$ 8% Situafion 2 $P=1$










Boots ap Type Ierror
Fisher’s exact test
Bootstrap TyPe Ierror $CA$
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